Campomanes, Angelly R.

HRN: 10-53-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
CEFUROXIME 1.5GM (VIAL)
06/22/2022
06/29/2022
IV
1.5gm
Q8
Incomplete Abortion Nonseptic.noninduced Leukocytosis 25.8
Waiting Final Action 
06/22/2022
CEFUROXIME 500MG (TAB)
06/22/2022
06/29/2022
PO
500mg
Q12
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: